AmBase Corp
Historical Data
View all| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 3, 2026 | $32.85 | $34.52 | $32.60 | $33.53 | 5.62M |
| Jul 2, 2026 | $33.10 | $33.20 | $32.77 | $32.85 | 4.91M |
| Jul 1, 2026 | $32.11 | $33.88 | $31.42 | $33.10 | 5.03M |
| Jun 30, 2026 | $32.72 | $33.79 | $31.70 | $32.11 | 3.35M |
| Jun 29, 2026 | $31.51 | $33.03 | $31.26 | $32.72 | 4.87M |
| Jun 28, 2026 | $31.74 | $32.22 | $31.24 | $31.51 | 4.43M |
| Jun 27, 2026 | $31.13 | $32.19 | $30.95 | $31.74 | 5.91M |
| Jun 26, 2026 | $30.02 | $31.45 | $29.79 | $31.13 | 6.58M |
Company Overview
AmBase Corp operates in the healthcare space within the Healthcare sector. The company generates the majority of its revenue from operating momentum, and has built a durable competitive position through scale, brand, and continued reinvestment. It serves customers globally and is headquartered in the United States. Reported figures on this page are generated for demonstration and are not investment advice.
Leadership
Board 11 · Independent 10 of 11| Date | Firm | Target | Rating |
|---|---|---|---|
| Jun 20 | Melius Research | $44.33 | Neutral |
| Jun 18 | Goldman Sachs | $30.79 | Hold |
| Jun 18 | Rosenblatt | $40.63 | Buy |
| Jun 3 | BofA Securities | — | Buy |
| May 9 | Mizuho | $33.31 | Hold |
| May 5 | Goldman Sachs | — | Strong Buy |
Politician Trades
View allWhat's Happening Right Now
- Aug 23, 2025 · Unrelated ↗ — A TradingView listing for HYOR (OTC:HYOR) appeared, unrelated to ABCP's own operations.
- May 10, 2025 · Unrelated ↗ — A TradingView listing for LPA (AMEX:LPA) appeared, not directly tied to ABCP news.
- Mar 29, 2023 · Profile ↗ — A GuruFocus net-worth profile piece on Philip M Halpern was published, tangential to ABCP.
- Mar 28, 2023 · Profile ↗ — A GuruFocus net-worth profile piece on John Ferrara was published, tangential to ABCP.
- Jul 2, 2020 · Quote ↗ — The Globe and Mail ran a standard stock price and news page for AmBase Corp (ABCP).
Snapshot
AmBase Corp reported zero revenue in FY 2025, underscoring its status as a non-operating or holding-stage entity. The company posted a net loss of $4.56M and an operating loss of $4.32M for the year. Operating cash flow was negative $2.33M, matching free cash flow of -$2.33M, indicating no capital expenditures offset the cash burn. Cash and equivalents stood at just $87.00K against total debt of $3.20M, leaving a thin liquidity cushion relative to obligations.
Bottom Line
ABCP shows no revenue generation alongside a multi-million dollar annual net loss and negative operating cash flow, while holding only $87K in cash against $3.2M in debt. This combination points to significant near-term liquidity risk absent external financing or a material corporate event. The available news flow lacks any concrete operational, legal, or strategic catalysts that would offset these fundamental financial pressures.